These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15892647)

  • 1. Type 2 diabetes, insulin secretion and beta-cell mass.
    Ahrén B
    Curr Mol Med; 2005 May; 5(3):275-86. PubMed ID: 15892647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
    Matveyenko AV; Butler PC
    Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
    Porte D
    Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.
    Leibowitz G; Yuli M; Donath MY; Nesher R; Melloul D; Cerasi E; Gross DJ; Kaiser N
    Diabetes; 2001 Feb; 50 Suppl 1():S113-7. PubMed ID: 11272167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets.
    Song SH; Rhodes CJ; Veldhuis JD; Butler PC
    Endocrinology; 2003 Aug; 144(8):3399-405. PubMed ID: 12865318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets.
    Björklund A; Grill V
    Diabetes; 1999 Jul; 48(7):1409-14. PubMed ID: 10389846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined lipidomic and proteomic analysis of isolated human islets exposed to palmitate reveals time-dependent changes in insulin secretion and lipid metabolism.
    Roomp K; Kristinsson H; Schvartz D; Ubhayasekera K; Sargsyan E; Manukyan L; Chowdhury A; Manell H; Satagopam V; Groebe K; Schneider R; Bergquist J; Sanchez JC; Bergsten P
    PLoS One; 2017; 12(4):e0176391. PubMed ID: 28448538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus.
    Kahn SE
    Am J Med; 2000 Apr; 108 Suppl 6a():2S-8S. PubMed ID: 10764844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
    Clark A; Matthews DR; Naylor BA; Wells CA; Hosker JP; Turner RC
    Diabetes Res; 1987 Feb; 4(2):51-5. PubMed ID: 2884060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans.
    Fritsche A; Madaus A; Stefan N; Tschritter O; Maerker E; Teigeler A; Häring H; Stumvoll M
    Diabetes; 2002 Feb; 51 Suppl 1():S234-9. PubMed ID: 11815485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet adaptation to insulin resistance: mechanisms and implications for intervention.
    Ahrén B; Pacini G
    Diabetes Obes Metab; 2005 Jan; 7(1):2-8. PubMed ID: 15642070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes.
    Laedtke T; Kjems L; Pørksen N; Schmitz O; Veldhuis J; Kao PC; Butler PC
    Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E520-8. PubMed ID: 10950818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.
    Butler AE; Janson J; Soeller WC; Butler PC
    Diabetes; 2003 Sep; 52(9):2304-14. PubMed ID: 12941770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.